Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Bipin Prasad who wrote (1032)	2/21/2000 5:24:00 PM
From: BigMoney	Respond to of 4474

Ariad stock up to 18.40 Euros on the FSE today. finance.uk.yahoo.com and another company listed on the FSE: finance.uk.yahoo.com I wonder if a foreign company like novartis would have an easier time accumulating shares without the U.S. shareholders picking up on it if it were done on a foreign exchange like the FSE? Would they have to register their shares with the SEC if their ownership went above 5%? I posted earlier that novartis was looking to get listed on the NYSE: Message 12773798 Could Ariad listing on the FSE simply be a precursor to a takeover? I really don't understand how being traded on the FSE improves "liquidity" as the press release states. If more people are buying and holding ariad stock in Germany, doesnt that reduce the float here in the US, or are the purchases/sales in Frankfurt done using ADR's which merely represent a ownership in the domestic shares. I'm confused. Any opinions would be welcome.